NCT02512497
- Conditions
- Cutaneous T-Cell Lymphoma, Hematologic Diseases, Hemic and Lymphatic Diseases, +22 more
- Locations
-
- The Ohio State University Cancer Center Columbus, Ohio, United States
Clinical trial condition
Cutaneous T-Cell Lymphoma
Explore clinical trials studying Cutaneous T-Cell Lymphoma. Study availability and eligibility vary by location and protocol.
40 public trials
7 recruiting studies
Cutaneous T-Cell Lymphoma trial results
Completed
Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms
NCT03493451
- Conditions
- ALK-Positive Anaplastic Large Cell Lymphoma, ALK-negative Anaplastic Large Cell Lymphoma, Adult Nasal Type Extranodal NK/T-cell Lymphoma, +36 more
- Locations
-
- British Columbia Cancer Agency the Vancouver Centre Vancouver, British Columbia, Canada
- Peking University Third Hospital Beijing, Beijing Municipality, China
- Beijing Hospital Beijing, Beijing Municipality, China
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
NCT00341939
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +37 more
- Locations
-
- National Cancer Institute (NCI), 9000 Rockville Pike Bethesda, Maryland, United States
NCT01728805
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- University of Alabama - Birmingham Birmingham, Alabama, United States
- Banner MD Anderson Gilbert, Arizona, United States
- City of Hope National Medical Center Duarte, California, United States
- UCLA Medical Center Los Angeles, California, United States
NCT01226472
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Stanford University Stanford, California, United States
NCT00071071
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
- Locations
-
- Stanford University Med. Ctr., Dept. of Dermatology Stanford, California, United States
- University of Texas, M.D. Anderson Cancer Center Houston, Texas, United States
NCT00896493
- Conditions
- Bacterial Infections and Mycoses, Bone Marrow Transplant Failure, Cutaneous T-Cell Lymphoma, +14 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States
Completed
Clinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin.
NCT00071084
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
- Locations
-
- Stanford University Med Ctr., Dept of Dermatology Stanford, California, United States
- University of Texas, M.D. Anderson Cancer Center Houston, Texas, United States
- Münster, Germany
- Stockholm, Sweden
Completed
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
NCT02643303
- Conditions
- Adenocarcinoma, Bladder Cancer, Breast Cancer, +65 more
- Locations
-
- Research Facility Atlanta, Georgia, United States
- Research Facility Lebanon, New Hampshire, United States
- Research Facility Buffalo, New York, United States
- Research Facility New York, United States
NCT02448381
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- University of Alabama Birmingham Birmingham, Alabama, United States
- University of Arizona Phoenix, Arizona, United States
- Mayo Clinic Scottsdale, Arizona, United States
- University of Arkansas Little Rock, Arkansas, United States